pimagedine has been researched along with Atrophy in 2 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Santoro, T | 1 |
Azevedo, CT | 1 |
E Silva, PMR | 1 |
Martins, MA | 1 |
Carvalho, VF | 1 |
Ito, J | 1 |
Uchida, H | 1 |
Yokote, T | 1 |
Ohtake, K | 1 |
Kobayashi, J | 1 |
2 other studies available for pimagedine and Atrophy
Article | Year |
---|---|
Glucocorticoids decrease the numbers and activation of mast cells by inducing the transactivation receptors of AGEs.
Topics: Animals; Apoptosis; Atrophy; Cell Count; Cell Line; Dexamethasone; Galectin 3; Glucocorticoids; Glyc | 2019 |
Fasting-induced intestinal apoptosis is mediated by inducible nitric oxide synthase and interferon-{gamma} in rat.
Topics: Animals; Apoptosis; Atrophy; Body Weight; Cell Proliferation; Food Deprivation; Gene Expression Regu | 2010 |